Genes associated with DCPs exhibited a highly significant cancer specific signature including AML, breast cancer and prostate cancer (Fig. 1D ).
← all excerpts
The epigenetic regulators EP300/CREBBP represent promising therapeutic targets in MLL-rearranged acute myeloid leukemia.
1
—
—